Page last updated: 2024-08-24

fluorodeoxyglucose f18 and HIV-Associated Lipodystrophy Syndrome

fluorodeoxyglucose f18 has been researched along with HIV-Associated Lipodystrophy Syndrome in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caton, MT; Hyun, H; Miskin, N1
Bredella, MA; Cypess, AM; Fitch, K; Grinspoon, S; Lim, R; Sass, CA; Stavrou, E; Torriani, M1
Bredella, MA; Cypess, AM; Fitch, K; Grinspoon, S; Lim, R; Stavrou, E; Torriani, M; Zanni, MV1
Bleeker-Rovers, CP; Corstens, FH; de Geus-Oei, LF; Koopmans, PP; Oyen, WJ; Smits, P; van der Ven, AJ; Zomer, B1

Other Studies

4 other study(ies) available for fluorodeoxyglucose f18 and HIV-Associated Lipodystrophy Syndrome

ArticleYear
18F-FDG Uptake in Subcutaneous Fat Preceding Clinical Diagnosis of Human Immunodeficiency Virus-Associated Lipodystrophy.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:12

    Topics: Fluorodeoxyglucose F18; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Subcutaneous Fat

2018
Deiodinase 2 expression is increased in dorsocervical fat of patients with HIV-associated lipohypertrophy syndrome.
    The Journal of clinical endocrinology and metabolism, 2012, Volume: 97, Issue:4

    Topics: Adipose Tissue, Brown; Adiposity; Atrophy; Back; Biopsy; Cohort Studies; Energy Metabolism; Fluorodeoxyglucose F18; Glucose; HIV-Associated Lipodystrophy Syndrome; Humans; Hypertrophy; Iodide Peroxidase; Iodothyronine Deiodinase Type II; Male; Middle Aged; Multimodal Imaging; Obesity, Abdominal; Positron-Emission Tomography; Subcutaneous Fat; Tissue Distribution; Tomography, X-Ray Computed; Up-Regulation

2012
Increased FDG uptake in association with reduced extremity fat in HIV patients.
    Antiviral therapy, 2013, Volume: 18, Issue:2

    Topics: Abdominal Fat; Body Composition; Extremities; Fluorodeoxyglucose F18; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Subcutaneous Fat; Tomography, X-Ray Computed

2013
F-18-fluorodeoxyglucose positron emission tomography for visualization of lipodystrophy in HIV-infected patients.
    AIDS (London, England), 2004, Dec-03, Volume: 18, Issue:18

    Topics: Adult; Antiretroviral Therapy, Highly Active; Blood Glucose; Fluorodeoxyglucose F18; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals

2004